Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Cholera Vaccine (Oral Route) market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Cholera Vaccine (Oral Route) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027. Segmented by Category Shanchol Dukoral Vaxchora Others Segmented by End User/Segment Hospital Research & Academic Laboratories Pharmaceutical & Biotechnology Companies Others Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Valneva Sanofi PaxVax EuBiologics

List of Figures

Figure Cholera Vaccine (Oral Route) Picture
Figure Global Cholera Vaccine (Oral Route) Sales Volume and Growth Rate (2016-2027)
Figure Global Cholera Vaccine (Oral Route) Sales Value and Growth Rate (2016-2027)
Figure Global Cholera Vaccine (Oral Route) Sales Value CAGR (2020-2027) by Region
Figure Global Cholera Vaccine (Oral Route) Sales Volume Market Share by Company, 2020
Figure Global Cholera Vaccine (Oral Route) Sales Value Market Share by Company, 2020
Figure Global Cholera Vaccine (Oral Route) Sales Value and Growth Rate (2016-2027)
Figure Product Picture of Shanchol
Figure Product Picture of Dukoral
Figure Product Picture of Vaxchora
Figure Product Picture of Others
Figure Global Cholera Vaccine (Oral Route) Sales Volume Market Share by Category, 2020
Figure Global Cholera Vaccine (Oral Route) Sales Value Market Share by Category, 2020
Figure North America Cholera Vaccine (Oral Route) Sales Volume Market Share by Category, 2020
Figure Europe Cholera Vaccine (Oral Route) Sales Volume Market Share by Category, 2020
Figure Asia Pacific Cholera Vaccine (Oral Route) Sales Volume Market Share by Category, 2020
Figure Central & South America Cholera Vaccine (Oral Route) Sales Volume Market Share by Category, 2020
Figure Middle East & Africa Cholera Vaccine (Oral Route) Sales Volume Market Share by Category, 2020
Figure Cholera Vaccine (Oral Route) in Hospital
Figure Global Cholera Vaccine (Oral Route) Market: Hospital (2016-2021)
Figure Cholera Vaccine (Oral Route) in Research & Academic Laboratories
Figure Global Cholera Vaccine (Oral Route) Market: Research & Academic Laboratories (2016-2021)
Figure Cholera Vaccine (Oral Route) in Pharmaceutical & Biotechnology Companies
Figure Global Cholera Vaccine (Oral Route) Market: Pharmaceutical & Biotechnology Companies (2016-2021)
Figure Cholera Vaccine (Oral Route) in Others
Figure Global Cholera Vaccine (Oral Route) Market: Others (2016-2021)
Figure Global Cholera Vaccine (Oral Route) Sales Volume Market Share by End User/Segment, 2020
Figure Global Cholera Vaccine (Oral Route) Sales Value Market Share by End User/Segment, 2020
Figure North America Cholera Vaccine (Oral Route) Sales Volume Market Share by End User/Segment, 2020
Figure Europe Cholera Vaccine (Oral Route) Sales Volume Market Share by End User/Segment, 2020
Figure Asia Pacific Cholera Vaccine (Oral Route) Sales Volume Market Share by End User/Segment, 2020
Figure Central & South America Cholera Vaccine (Oral Route) Sales Volume Market Share by End User/Segment, 2020
Figure Middle East & Africa Cholera Vaccine (Oral Route) Sales Volume Market Share by End User/Segment, 2020
Figure Global Cholera Vaccine (Oral Route) Sales Volume Market Share by Region (2016-2021)
Figure Global Cholera Vaccine (Oral Route) Sales Value Market Share by Region (2016-2021)
Figure North America Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure North America Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Europe Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Europe Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Asia Pacific Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure North America Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Central & South America Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Europe Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Middle East & Africa Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure China Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure North America Cholera Vaccine (Oral Route) Sales Volume Market Share by Country, 2020
Figure Japan Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure United States Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Asia Other Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Canada Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Canada Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Mexico Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Mexico Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Europe Cholera Vaccine (Oral Route) Sales Volume Market Share by Country, 2020
Figure Europe Cholera Vaccine (Oral Route) Value Market Share by Country, 2020
Figure Germany Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Germany Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure France Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure France Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure UK Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure UK Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Italy Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Italy Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Russia Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Russia Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Spain Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Spain Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Asia Pacific Cholera Vaccine (Oral Route) Sales Volume Market Share by Country, 2020
Figure Asia Pacific Cholera Vaccine (Oral Route) Value Market Share by Country, 2020
Figure China Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure China Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Japan Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Japan Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Korea Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Korea Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Southeast Asia Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Southeast Asia Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure India Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure India Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Australasia Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Australasia Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Central & South America Cholera Vaccine (Oral Route) Sales Volume Market Share by Country, 2020
Figure Central & South America Cholera Vaccine (Oral Route) Sales Value Market Share by Country, 2020
Figure Brazil Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Brazil Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Argentina Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Argentina Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Colombia Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Colombia Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Middle East & Africa Cholera Vaccine (Oral Route) Sales Volume Market Share by Country, 2020
Figure Middle East & Africa Cholera Vaccine (Oral Route) Value Market Share by Country, 2020
Figure Iran Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Iran Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure South Africa Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure South Africa Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Israel Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Israel Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Turkey Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Turkey Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Saudi Arabia Cholera Vaccine (Oral Route) Sales Volume Status (2016-2021)
Figure Saudi Arabia Cholera Vaccine (Oral Route) Sales Value Status (2016-2021)
Figure Cholera Vaccine (Oral Route) Supply Chain Analysis
Figure Cholera Vaccine (Oral Route) Production Process Chart Analysis
Figure Cholera Vaccine (Oral Route) Manufacturing Cost Analysis
Figure Global Cholera Vaccine (Oral Route) Sales Volume Forecast (2022-2027)
Figure Global Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure North America Cholera Vaccine (Oral Route) Sales Volume Forecast (2022-2027)
Figure North America Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Global Cholera Vaccine (Oral Route) Sales Value Growth Rate Forecast (2022-2027)
Figure Europe Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Asia Pacific Cholera Vaccine (Oral Route) Sales Volume Forecast (2022-2027)
Figure North America Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Central & South America Cholera Vaccine (Oral Route) Sales Volume Forecast (2022-2027)
Figure Europe Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Middle East & Africa Cholera Vaccine (Oral Route) Sales Volume Forecast (2022-2027)
Figure China Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Japan Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Asia Other Cholera Vaccine (Oral Route) Sales Value Forecast (2022-2027)
Figure Valneva Cholera Vaccine (Oral Route) Sales Volume Market Share Globally (2019-2021)
Figure Valneva Cholera Vaccine (Oral Route) Sales Value Market Share Globally (2019-2021)
Figure Sanofi Cholera Vaccine (Oral Route) Sales Volume Market Share Globally (2019-2021)
Figure Sanofi Cholera Vaccine (Oral Route) Sales Value Market Share Globally (2019-2021)
Figure PaxVax Cholera Vaccine (Oral Route) Sales Volume Market Share Globally (2019-2021)
Figure PaxVax Cholera Vaccine (Oral Route) Sales Value Market Share Globally (2019-2021)
Figure EuBiologics Cholera Vaccine (Oral Route) Sales Volume Market Share Globally (2019-2021)
Figure EuBiologics Cholera Vaccine (Oral Route) Sales Value Market Share Globally (2019-2021)

Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Cholera Vaccine (Oral Route) Market Status and Forecast (2016-2027) 1.3.2 Global Cholera Vaccine (Oral Route) Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Cholera Vaccine (Oral Route) Supply by Company 2.1 Global Cholera Vaccine (Oral Route) Sales Volume by Company 2.2 Global Cholera Vaccine (Oral Route) Sales Value by Company 2.3 Global Cholera Vaccine (Oral Route) Price by Company 2.4 Cholera Vaccine (Oral Route) Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate3 Global and Regional Cholera Vaccine (Oral Route) Market Status by Category 3.1 Cholera Vaccine (Oral Route) Category Introduction 3.1.1 Shanchol 3.1.2 Dukoral 3.1.3 Vaxchora 3.1.4 Others 3.2 Global Cholera Vaccine (Oral Route) Market by Category 3.2.1 Global Cholera Vaccine (Oral Route) Sales Volume by Category (2016-2021) 3.2.2 Global Cholera Vaccine (Oral Route) Sales Value by Category (2016-2021) 3.2.3 Global Cholera Vaccine (Oral Route) Price by Category (2016-2021) 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Cholera Vaccine (Oral Route) Market Status by End User/Segment 4.1 Cholera Vaccine (Oral Route) Segment by End User/Segment 4.1.1 Hospital 4.1.2 Research & Academic Laboratories 4.1.3 Pharmaceutical & Biotechnology Companies 4.1.4 Others 4.2 Global Cholera Vaccine (Oral Route) Market by End User/Segment 4.2.1 Global Cholera Vaccine (Oral Route) Sales Volume by End User/Segment (2016-2021) 4.2.2 Global Cholera Vaccine (Oral Route) Sales Value by End User/Segment (2016-2021) 4.2.3 Global Cholera Vaccine (Oral Route) Price by End User/Segment (2016-2021) 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Cholera Vaccine (Oral Route) Market Status by Region 5.1 Global Cholera Vaccine (Oral Route) Market by Region 5.1.1 Global Cholera Vaccine (Oral Route) Sales Volume by Region 5.1.2 Global Cholera Vaccine (Oral Route) Sales Value by Region 5.2 North America Cholera Vaccine (Oral Route) Market Status 5.3 Europe Cholera Vaccine (Oral Route) Market Status 5.4 Asia Pacific Cholera Vaccine (Oral Route) Market Status 5.5 Central & South America Cholera Vaccine (Oral Route) Market Status 5.6 Middle East & Africa Cholera Vaccine (Oral Route) Market Status6 North America Cholera Vaccine (Oral Route) Market Status 6.1 North America Cholera Vaccine (Oral Route) Market by Country 6.1.1 North America Cholera Vaccine (Oral Route) Sales Volume by Country (2016-2021) 6.1.2 North America Cholera Vaccine (Oral Route) Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Cholera Vaccine (Oral Route) Market Status 7.1 Europe Cholera Vaccine (Oral Route) Market by Country 7.1.1 Europe Cholera Vaccine (Oral Route) Sales Volume by Country (2016-2021) 7.1.2 Europe Cholera Vaccine (Oral Route) Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Cholera Vaccine (Oral Route) Market Status 8.1 Asia Pacific Cholera Vaccine (Oral Route) Market by Country 8.1.1 Asia Pacific Cholera Vaccine (Oral Route) Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Cholera Vaccine (Oral Route) Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Cholera Vaccine (Oral Route) Market Status 9.1 Central & South America Cholera Vaccine (Oral Route) Market by Country 9.1.1 Central & South America Cholera Vaccine (Oral Route) Sales Volume by Country (2016-2021) 9.1.2 Central & South America Cholera Vaccine (Oral Route) Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Cholera Vaccine (Oral Route) Market Status 10.1 Middle East & Africa Cholera Vaccine (Oral Route) Market by Country 10.1.1 Middle East & Africa Cholera Vaccine (Oral Route) Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Cholera Vaccine (Oral Route) Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Cholera Vaccine (Oral Route) Manufacturing Cost Analysis 11.5 Cholera Vaccine (Oral Route) Sales Channel and Distributors Analysis 11.5.1 Cholera Vaccine (Oral Route) Sales Channel 11.5.2 Cholera Vaccine (Oral Route) Distributors 11.6 Cholera Vaccine (Oral Route) Downstream Major Buyers12 Global Cholera Vaccine (Oral Route) Market Forecast by Category and by End User/Segment 12.1 Global Cholera Vaccine (Oral Route) Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Cholera Vaccine (Oral Route) Forecast by Category 12.2.1 Global Cholera Vaccine (Oral Route) Sales Volume Forecast by Category 12.2.2 Global Cholera Vaccine (Oral Route) Sales Value Forecast by Category 12.2.3 Global Cholera Vaccine (Oral Route) Price Forecast by Category 12.3 Global Cholera Vaccine (Oral Route) Forecast by End User/Segment 12.3.1 Global Cholera Vaccine (Oral Route) Sales Volume Forecast by End User/Segment 12.3.2 Global Cholera Vaccine (Oral Route) Sales Value Forecast by End User/Segment 12.3.3 Global Cholera Vaccine (Oral Route) Price Forecast by End User/Segment13 Global Cholera Vaccine (Oral Route) Market Forecast by Region/Country 13.1 Global Cholera Vaccine (Oral Route) Market Forecast by Region (2022-2027) 13.1.1 Global Cholera Vaccine (Oral Route) Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Cholera Vaccine (Oral Route) Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Valneva 14.1.1 Company Information 14.1.2 Cholera Vaccine (Oral Route) Product Introduction 14.1.3 Valneva Cholera Vaccine (Oral Route) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Sanofi 14.2.1 Company Information 14.2.2 Cholera Vaccine (Oral Route) Product Introduction 14.2.3 Sanofi Cholera Vaccine (Oral Route) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 PaxVax 14.3.1 Company Information 14.3.2 Cholera Vaccine (Oral Route) Product Introduction 14.3.3 PaxVax Cholera Vaccine (Oral Route) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 EuBiologics 14.4.1 Company Information 14.4.2 Cholera Vaccine (Oral Route) Product Introduction 14.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis ...15 Conclusion16 Methodology